AR039213A1 - Porfolio de pronostico del cancer de mamas - Google Patents

Porfolio de pronostico del cancer de mamas

Info

Publication number
AR039213A1
AR039213A1 ARP030101134A ARP030101134A AR039213A1 AR 039213 A1 AR039213 A1 AR 039213A1 AR P030101134 A ARP030101134 A AR P030101134A AR P030101134 A ARP030101134 A AR P030101134A AR 039213 A1 AR039213 A1 AR 039213A1
Authority
AR
Argentina
Prior art keywords
cancer
mamas
forecast
forms
genes
Prior art date
Application number
ARP030101134A
Other languages
English (en)
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29215884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR039213(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of AR039213A1 publication Critical patent/AR039213A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un método para pronosticar la metástasis en un paciente con cáncer de mamas que incluye la identificación de la modulación diferencial de cada gen (relativo a la expresión de los mismos genes en una población normal) en una combinación de genes seleccionados de un grupo formado por genes. Los porfolios de expresión génica y kits para emplear el método son aspectos adicionales de la invención.
ARP030101134A 2002-03-29 2003-04-01 Porfolio de pronostico del cancer de mamas AR039213A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36878902P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
AR039213A1 true AR039213A1 (es) 2005-02-09

Family

ID=29215884

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101134A AR039213A1 (es) 2002-03-29 2003-04-01 Porfolio de pronostico del cancer de mamas

Country Status (11)

Country Link
US (1) US7473526B2 (es)
EP (1) EP1367138B1 (es)
JP (1) JP2003325192A (es)
KR (1) KR20030078805A (es)
CN (1) CN1495274A (es)
AR (1) AR039213A1 (es)
AU (1) AU2003203557B2 (es)
BR (1) BR0303092A (es)
CA (1) CA2422303A1 (es)
DE (1) DE60317606T2 (es)
MX (1) MXPA03002864A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361433A3 (en) * 2002-04-09 2005-02-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
US20050003422A1 (en) * 2003-07-01 2005-01-06 Mitch Reponi Methods for assessing and treating cancer
WO2005083429A2 (en) * 2004-02-20 2005-09-09 Veridex, Llc Breast cancer prognostics
WO2005106043A2 (en) * 2004-04-23 2005-11-10 Exagen Diagnostics, Inc. Breast cancer gene expression biomarkers
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
EP1983046A4 (en) * 2006-02-03 2009-03-25 Messengerscape Co Ltd GENERAL GROUP APPLICABLE TO CANCER PROSTICE
WO2008073578A2 (en) 2006-12-08 2008-06-19 Iowa State University Research Foundation, Inc. Plant genes involved in nitrate uptake and metabolism
WO2010003020A1 (en) * 2008-07-01 2010-01-07 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for assessment of clinical infertility
ES2338843B1 (es) * 2008-07-02 2011-01-24 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Huella genomica de cancer de mama.
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
WO2012070056A2 (en) 2010-11-23 2012-05-31 Krisani Biosciences (P) Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
KR101287600B1 (ko) * 2011-01-04 2013-07-18 주식회사 젠큐릭스 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US635152A (en) * 1899-06-05 1899-10-17 Melancthon S Shotwell Car-body bolster.
US6350576B1 (en) * 1994-12-20 2002-02-26 Cold Spring Harbor Laboratory Cancer detection probes
ATE270712T1 (de) 1995-03-17 2004-07-15 Wayne John Cancer Inst Nachweis von melanomenmetastasen unter verwendung eines mehrfachmarker-tests
US6275814B1 (en) * 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) * 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
US6037129A (en) * 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6175624B1 (en) * 1999-03-05 2001-01-16 Centurion International, Inc. Method for connecting a battery circuit in a cellular telephone
AU3755300A (en) 1999-03-15 2000-10-04 Eos Biotechnology, Inc. Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
US6175824B1 (en) * 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators
CN1188031C (zh) * 1999-07-15 2005-02-09 研究发展基金会 促肾上腺皮质素释放因子受体－2缺陷型小鼠及其用途
AU2003217421A1 (en) * 2002-02-19 2003-09-09 Idec Pharmaceuticals Corporation Prostate specific genes and the use thereof in design or therapeutics
US20050054826A1 (en) * 2003-05-19 2005-03-10 Rosetta Inpharmatics Llc Human diaphanous-3 gene and methods of use therefor

Also Published As

Publication number Publication date
BR0303092A (pt) 2004-09-08
CN1495274A (zh) 2004-05-12
AU2003203557B2 (en) 2007-05-24
CA2422303A1 (en) 2003-09-29
DE60317606D1 (de) 2008-01-03
JP2003325192A (ja) 2003-11-18
US7473526B2 (en) 2009-01-06
EP1367138A3 (en) 2004-03-10
EP1367138A2 (en) 2003-12-03
KR20030078805A (ko) 2003-10-08
DE60317606T2 (de) 2008-10-23
MXPA03002864A (es) 2004-08-11
AU2003203557A1 (en) 2003-10-23
EP1367138B1 (en) 2007-11-21
US20030190656A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
AR039210A1 (es) Panel de diagnostico del cancer
AR039213A1 (es) Porfolio de pronostico del cancer de mamas
AR043808A1 (es) Pronostico de cancer colorrectal
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
UY31105A1 (es) Predicción pronóstica del melanoma
CR9315A (es) Metodos y sistemas para el diagnostico, pronostico y seleccion del tratamiento de la leucemia
ES2570359T3 (es) Regiones ultraconservadas que codifican ARNnc
EA202091333A1 (ru) Способы активации, модификации и экспансии t-клеток для лечения рака и связанных с ним злокачественных заболеваний
CR9298A (es) Marcadores farmacogenomicos para el pronostico de tumores solidos
BRPI0606287A2 (pt) processo para a produção de silicones monofuncionais monodispersos e dispersos limitados
AR057628A1 (es) Injertos capilares derivados de cabello extirpado
AR044099A1 (es) Pronostico de cancer de mama
AR113680A1 (es) Sistemas y métodos para identificar usuarios en base a los datos de voz y datos de consumo de medios
CL2008001057A1 (es) Agente para el tratamiento de micosis producida por saprolegnia, achlya y/o aphanomyces en peces, el cual comprende al menos un fungicida seleccionado entre a) inhibidores de l a mitosis y division celular, b) inhiidores de la sintesis de ergosterol o, c) derivados de piridina, benzopiranona, carbonitrilo,quinolinas, entre otras.
WO2008037700A3 (en) Methods for breast cancer prognosis
CL2019002633A1 (es) Sistema para predecir el pronóstico y el beneficio de la quimioterapia adyuvante para pacientes con estadio ii y iii de cáncer gástrico.
DE60138415D1 (de) Expression von p2y-purinergem rezeptor zur identifizierung präneoplastischer und neoplastischer zustände
CR10280A (es) Anticuerpos de la efgl7 y metodos de uso
CO2019003583A2 (es) Estructuras eficientes de datos para la representación de información bioinformática
AR039211A1 (es) Evaluacion del cancer colorectal
CL2022001002A1 (es) Método in vitro para determinar el riesgo a desarrollar cáncer de mama en un sujeto
AR039617A1 (es) Evaluacion del cancer colorectal
Hemelrijk Roman citizenship and the integration of women into the local towns of the Latin West
BRPI0407070A (pt) Oligonucleotìdeos antisentido que inibem a expressão de hif-1
Tollefson Core Ensemble to Perform New Chamber Music Theatre Work at the U of M Crookston Celebrating the Lives of Three Significant Latin Women

Legal Events

Date Code Title Description
FA Abandonment or withdrawal